The postoperative platelet-to-lymphocyte ratio predicts the outcome of patients undergoing pancreaticoduodenectomy for pancreatic head cancer.

[1]  J. D'haese,et al.  Effect of platelet inhibition with perioperative aspirin on survival in patients undergoing curative resection for pancreatic cancer: a propensity score matched analysis , 2021, BMC Surgery.

[2]  A. Jemal,et al.  Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries , 2021, CA: a cancer journal for clinicians.

[3]  M. Sekimoto,et al.  The past, present, and future status of multimodality treatment for resectable/borderline resectable pancreatic ductal adenocarcinoma , 2020, Surgery Today.

[4]  P. Hjemdahl,et al.  Increased platelet reactivity and platelet–leukocyte aggregation after elective coronary bypass surgery , 2018, Platelets.

[5]  J. Manson,et al.  Regular Use of Aspirin or Non-Aspirin Nonsteroidal Anti-Inflammatory Drugs Is Not Associated With Risk of Incident Pancreatic Cancer in Two Large Cohort Studies. , 2018, Gastroenterology.

[6]  S. Tucker,et al.  Platelets and cancer angiogenesis nexus , 2017, Cancer and Metastasis Reviews.

[7]  D. Gouma,et al.  The 2016 update of the International Study Group (ISGPS) definition and grading of postoperative pancreatic fistula: 11 Years After , 2017, Surgery.

[8]  K. Yanaga,et al.  Preoperative Platelet-to-Albumin Ratio Predicts Prognosis of Patients with Pancreatic Ductal Adenocarcinoma After Pancreatic Resection. , 2017, Anticancer research.

[9]  K. Soo,et al.  Preoperative platelet–lymphocyte ratio is an independent prognostic marker and superior to carcinoembryonic antigen in colorectal peritoneal carcinomatosis patients undergoing cytoreductive surgery and hyperthermic intraperitoneal chemotherapy , 2017, International Journal of Clinical Oncology.

[10]  D. Cameron,et al.  ADD-ASPIRIN: A phase III, double-blind, placebo controlled, randomised trial assessing the effects of aspirin on disease recurrence and survival after primary therapy in common non-metastatic solid tumours , 2016, Contemporary clinical trials.

[11]  Y. Ku,et al.  Preoperative independent prognostic factors in patients with borderline resectable pancreatic ductal adenocarcinoma following curative resection: the neutrophil-lymphocyte and platelet-lymphocyte ratios , 2016, Surgery Today.

[12]  M. Ikeguchi,et al.  Prognostic indicators based on inflammatory and nutritional factors after pancreaticoduodenectomy for pancreatic cancer , 2016, Surgery Today.

[13]  M. Gonen,et al.  Postoperative complications and overall survival after pancreaticoduodenectomy for pancreatic ductal adenocarcinoma , 2016, Journal of surgical oncology.

[14]  K. Yanaga,et al.  Preoperative platelet to lymphocyte ratio predicts outcome of patients with pancreatic ductal adenocarcinoma after pancreatic resection. , 2015, Surgery.

[15]  T. Burnouf,et al.  Platelets effects on tumor growth. , 2014, Seminars in oncology.

[16]  J. Jacob,et al.  Reduced dissemination of circulating tumor cells with no-touch isolation surgical technique in patients with pancreatic cancer. , 2014, JAMA surgery.

[17]  Masaya Suenaga,et al.  Modified Blumgart Anastomosis for Pancreaticojejunostomy: Technical Improvement in Matched Historical Control Study , 2014, Journal of Gastrointestinal Surgery.

[18]  D. Quail,et al.  Microenvironmental regulation of tumor progression and metastasis , 2013, Nature Medicine.

[19]  A. Hinke,et al.  Adjuvant chemotherapy with gemcitabine and long-term outcomes among patients with resected pancreatic cancer: the CONKO-001 randomized trial. , 2013, JAMA.

[20]  M. Ishikawa,et al.  Perioperative immune responses in cancer patients undergoing digestive surgeries , 2009, World journal of surgical oncology.

[21]  N. Demartines,et al.  Classification of Surgical Complications: A New Proposal With Evaluation in a Cohort of 6336 Patients and Results of a Survey , 2004, Annals of Surgery.

[22]  A. Ordinas,et al.  Tumor‐cell‐induced platelet aggregation is a glycoprotein‐dependent and lipoxygenase‐associated process , 1987, International Journal of Cancer.

[23]  J. Harmon,et al.  Metastasis-promoting role of extravasated platelet activation in tumor. , 2015, The Journal of surgical research.